Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avelumab and Methotrexate in Low-risk Gestational Trophoblastic Neoplasias
NCT04396223Phase 2Recruiting
- Sponsor
- Hospices Civils de Lyon
- Start
- Feb 2020
- Primary completion
- Apr 2025
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of avelumab in gestational trophoblastic neoplasia (GTN), sponsored by Hospices Civils de Lyon. Started Feb 2020; status: recruiting.
02
Drugs
avelumab
03
Conditions
gestational trophoblastic neoplasia (GTN)
Beyond the preview
Go deeper on NCT04396223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04396223.